Kazia Therapeutics Limited

Quick facts

Phase 1 pipeline

• [14C]-Paxalisib Capsule
• EVT801
• Part A: Dose Escalation of Cantrixil
• Part B: Expansion Cohort of Cantrixil

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kazia Therapeutics Limited portfolio CI brief
• Kazia Therapeutics Limited pipeline updates RSS

Related

• Sector hub: All tracked pharma companies